Vimta Labs Limited (NSE:VIMTALABS)
India · Delayed Price · Currency is INR 508.90
+4.40 (0.87%)
Nov 11, 2026, 3:00 PM IST
Vimta Labs Market Cap
Vimta Labs has a market cap or net worth of 22.7 billion as of November 10, 2026. Its market cap has decreased by 22.64% in one year.
Market Cap
22.70B
Enterprise Value
21.99B
Revenue
4.31B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.62
ChartMarket Cap Chart
Since January 10, 2002, Vimta Labs's market cap has increased from 19.85M to 22.70B, an increase of 114,251.85%. That is a compound annual growth rate of 32.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 22.70B | -16.12% |
| Dec 31, 2025 | 27.06B | 22.39% |
| Dec 31, 2024 | 22.11B | 147.00% |
| Dec 29, 2023 | 8.95B | -7.56% |
| Dec 30, 2022 | 9.68B | 7.16% |
| Dec 31, 2021 | 9.04B | 134.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.46T |
| Divi's Laboratories | 2.74T |
| Laurus Labs | 1.26T |
| Lenskart Solutions | 1.26T |
| Dishman Carbogen Amcis | 24.55B |
| Sakar Healthcare | 21.69B |
| Medi Assist Healthcare Services | 21.10B |
| Panacea Biotec | 21.06B |